Sanford C. Bernstein Increases UnitedHealth Group (NYSE:UNH) Price Target to $433.00

Key Points

• Sanford C. Bernstein has increased the price target for UnitedHealth Group (NYSE:UNH) from $379.00 to $433.00, indicating a potential upside of 16.21% from the previous close.
• The company reported earnings per share (EPS) of $4.08 for the last quarter, missing the consensus estimate of $4.45 by $0.37, while revenue grew 12.9% year-over-year.
• Institutional investors hold 87.86% of UnitedHealth Group's stock, with significant new investments from firms like Norges Bank and Berkshire Hathaway.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target upped by investment analysts at Sanford C. Bernstein from $379.00 to $433.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has an "outperform" rating on the healthcare conglomerate's stock. Sanford C. Bernstein's price objective would indicate a potential upside of 16.21% from the company's previous close.

Several other equities research analysts have also recently issued reports on the stock. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. KeyCorp lifted their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an "overweight" rating in a research report on Wednesday. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Finally, Morgan Stanley lifted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research report on Friday, September 12th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $369.73.

UnitedHealth Group Trading Up 2.5%

Shares of UNH traded up $8.94 during mid-day trading on Wednesday, hitting $372.60. The company had a trading volume of 3,677,904 shares, compared to its average volume of 12,711,535. The business's 50-day simple moving average is $311.44 and its 200-day simple moving average is $352.42. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market cap of $337.45 billion, a PE ratio of 16.16, a P/E/G ratio of 2.33 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently added to or reduced their stakes in UNH. Norges Bank bought a new stake in UnitedHealth Group during the second quarter valued at $3,837,207,000. Nuveen LLC bought a new stake in UnitedHealth Group during the first quarter valued at $3,846,764,000. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Berkshire Hathaway Inc bought a new position in shares of UnitedHealth Group during the second quarter worth about $1,572,193,000. Finally, Dodge & Cox grew its position in shares of UnitedHealth Group by 117.7% during the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after acquiring an additional 4,730,192 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.